- Home
- TKR vs LEGN Comparison
TKR vs LEGN Comparison
Compare TKR & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKR | LEGN |
|---|---|---|
| Founded | 1899 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TKR | LEGN |
|---|---|---|
| Price | $88.62 | $22.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $82.70 | $69.58 |
| AVG Volume (30 Days) | 651.0K | ★ 2.5M |
| Earning Date | 02-04-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | ★ $4,544,400,000.00 | $909,045,000.00 |
| Revenue This Year | $0.37 | $68.52 |
| Revenue Next Year | $3.31 | $48.63 |
| P/E Ratio | $21.51 | ★ N/A |
| Revenue Growth | N/A | ★ 74.75 |
| 52 Week Low | $56.20 | $20.21 |
| 52 Week High | $91.00 | $45.30 |
Technical Indicators
Market Signals| Indicator | TKR | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 43.24 |
| Support Level | $84.08 | $20.21 |
| Resistance Level | $91.00 | $22.07 |
| Average True Range (ATR) | 1.76 | 0.80 |
| MACD | 0.08 | 0.22 |
| Stochastic Oscillator | 63.12 | 74.26 |
Price Performance
Historical ComparisonAbout TKR Timken Company (The)
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.